Laurence Guianvarc’h

Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders

Jihad El Andari, Edith Renaud-Gabardos, Warut Tulalamba et al. · Science Advances · 2022 · 82 citations · Full text

Therapeutic Gene Delivery, Engineering, In Vivo Gene Therapy +22

Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome

Fanny Collaud, Giulia Bortolussi, Laurence Guianvarc’h et al. · Molecular Therapy — Methods & Clinical Development · 2018 · 59 citations · Full text

The EB66® cell line as a valuable cell substrate for MVA-based vaccines production

Arnaud Léon, Anne-Laure David, Brice Madeline et al. · Vaccine · 2016 · 23 citations · Full text

Cell Susceptibility, Viral Replication, Synthetic Virology +17